Barclays turns more bullish on 10x Genomics, Inc. (TXG) despite uneven research spending

MSN
2025.12.23 03:32
portai
I'm PortAI, I can summarize articles.

Barclays analyst Luke Sergott raised the price target for 10x Genomics, Inc. (TXG) from $17 to $22 while maintaining an Overweight rating, despite uneven research spending.

Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer